UOSD SARCOMAS AND RARE TUMORS
Head: Virginia Ferraresi, MD
The UOSD is actively involved in national and international clinical trials (phase 1,2, and 3 trials) exploring new drugs and approaches in sarcomas (soft tissue sarcomas, GIST, high-grade bone sarcomas, osteosarcoma, and Ewing sarcomas) and muscle-skeletal benign aggressive tumors (like Tenosynovial Giant Cell Tumours). It is also one of the centre of the Italian Sarcoma Group (ISG) and Dr. Ferraresi is a member of the Executive Committee of the Group. Dr. Ferraresi is moreover a component of the board for clinical guidelines for soft tissue sarcomas and GIST of AIOM (Associazione Italiana di Oncologia Medica), She is also in the board of EURACAN guidelines for soft tissue and bone sarcomas. Research activity is conducted with the involvement of 2 fully trained data manager specifically addressed to follow clinical trials in good clinical practice.